Colgate-Palmolive (CL) Shares Sold by Chicago Equity Partners LLC

Chicago Equity Partners LLC trimmed its stake in Colgate-Palmolive (NYSE:CL) by 75.9% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 30,805 shares of the company’s stock after selling 97,210 shares during the period. Chicago Equity Partners LLC’s holdings in Colgate-Palmolive were worth $2,244,000 as of its most recent SEC filing.

Several other hedge funds also recently bought and sold shares of the stock. Hayek Kallen Investment Management boosted its stake in Colgate-Palmolive by 0.8% in the first quarter. Hayek Kallen Investment Management now owns 13,584 shares of the company’s stock worth $994,000 after buying an additional 103 shares in the last quarter. Gould Asset Management LLC CA boosted its stake in shares of Colgate-Palmolive by 5.1% during the first quarter. Gould Asset Management LLC CA now owns 5,270 shares of the company’s stock valued at $386,000 after purchasing an additional 254 shares during the period. ARGI Investment Services LLC boosted its stake in shares of Colgate-Palmolive by 10.3% during the first quarter. ARGI Investment Services LLC now owns 15,199 shares of the company’s stock valued at $1,113,000 after purchasing an additional 1,421 shares during the period. Choate Investment Advisors boosted its stake in shares of Colgate-Palmolive by 3.5% during the first quarter. Choate Investment Advisors now owns 35,769 shares of the company’s stock valued at $2,618,000 after purchasing an additional 1,202 shares during the period. Finally, Alliancebernstein L.P. boosted its stake in shares of Colgate-Palmolive by 4.2% during the first quarter. Alliancebernstein L.P. now owns 1,899,356 shares of the company’s stock valued at $139,014,000 after purchasing an additional 77,414 shares during the period. Institutional investors own 72.83% of the company’s stock.

Shares of Colgate-Palmolive (NYSE CL) opened at $75.15 on Tuesday. Colgate-Palmolive has a 52 week low of $63.43 and a 52 week high of $77.27. The company has a market capitalization of $65,989.61, a price-to-earnings ratio of 29.02, a P/E/G ratio of 3.44 and a beta of 0.81. The company has a quick ratio of 0.92, a current ratio of 1.23 and a debt-to-equity ratio of 24.42.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings results on Friday, October 27th. The company reported $0.73 EPS for the quarter, hitting analysts’ consensus estimates of $0.73. Colgate-Palmolive had a return on equity of 2,782.56% and a net margin of 15.10%. The company had revenue of $3.97 billion during the quarter, compared to analyst estimates of $3.94 billion. During the same quarter last year, the firm posted $0.73 earnings per share. The firm’s revenue was up 2.8% on a year-over-year basis. analysts expect that Colgate-Palmolive will post 2.88 EPS for the current fiscal year.

A number of analysts have recently weighed in on the company. Zacks Investment Research lowered Colgate-Palmolive from a “hold” rating to a “sell” rating in a research note on Tuesday, December 19th. Macquarie raised Colgate-Palmolive from a “neutral” rating to an “outperform” rating and set a $81.00 price objective for the company in a research note on Tuesday, December 19th. Deutsche Bank assumed coverage on Colgate-Palmolive in a research note on Wednesday, December 13th. They set a “hold” rating and a $75.00 price objective for the company. Societe Generale lowered Colgate-Palmolive from a “hold” rating to a “sell” rating and set a $66.00 price objective for the company. in a research note on Wednesday, November 29th. They noted that the move was a valuation call. Finally, KeyCorp reissued a “hold” rating on shares of Colgate-Palmolive in a research note on Saturday, November 25th. Three equities research analysts have rated the stock with a sell rating, thirteen have issued a hold rating and five have issued a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus price target of $76.33.

In other Colgate-Palmolive news, insider Victoria L. Dolan sold 9,000 shares of the stock in a transaction on Tuesday, November 14th. The stock was sold at an average price of $73.41, for a total value of $660,690.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Jennifer Daniels sold 7,375 shares of the stock in a transaction on Wednesday, December 13th. The stock was sold at an average price of $73.18, for a total value of $539,702.50. Following the completion of the transaction, the insider now owns 38,691 shares of the company’s stock, valued at approximately $2,831,407.38. The disclosure for this sale can be found here. Insiders sold 181,048 shares of company stock valued at $13,168,995 in the last ninety days. 1.02% of the stock is currently owned by insiders.

ILLEGAL ACTIVITY WARNING: This piece was posted by Community Financial News and is owned by of Community Financial News. If you are reading this piece on another website, it was copied illegally and reposted in violation of United States & international copyright and trademark legislation. The original version of this piece can be read at https://www.com-unik.info/2017/12/26/colgate-palmolive-cl-shares-sold-by-chicago-equity-partners-llc.html.

Colgate-Palmolive Profile

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit